Han-Gu Lee

Chief Executive Officer at RedoxBio Co., Ltd.

Net worth: 5 M $ as of 31/05/2024

77 year

Health Technology

Consumer Services

Profile

Han-Gu Lee is currently the Chairman & Co-Chief Executive Officer at RedoxBio Co., Ltd.
He previously held the position of Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd.
and HLB Pharmaceutical Co., Ltd.
He has an undergraduate and doctorate degree from Sungkyunkwan University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
DAE HWA PHARM CO., LTD. 3.34%	05/04/2024	621,300 ( 3.34% )	4 M $	31/05/2024
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. 0.41%	31/03/2023	100,000 ( 0.41% )	239 971 $	31/12/2020

Han-Gu Lee active positions

Companies	Position	Start
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea.	Chief Executive Officer	-